Related Experiment Video
Updated: Dec 30, 2025

Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
Electrical Impedance Spectroscopy for Characterization of Prostate PC-3 and DU 145 Cancer Cells.
Electrical Impedance Spectroscopy (EIS) can distinguish between metastatic prostate cancer cells (PC-3) and non-metastatic cells (DU 145). This technique shows potential as a diagnostic tool for cancer cell metastasis.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Electrical Engineering
Background:
- Prostate cancer cell lines PC-3 and DU 145 exhibit different metastatic behaviors.
- Distinguishing metastatic from non-metastatic cancer cells is crucial for diagnosis and treatment.
- Electrical Impedance Spectroscopy (EIS) is a non-invasive technique for characterizing cell properties.
Purpose of the Study:
- To compare the impedance profiles of PC-3 and DU 145 prostate cancer cells using EIS.
- To evaluate the potential of EIS as a diagnostic tool for differentiating metastatic and non-metastatic cancer cells.
Main Methods:
- Recorded impedance profiles of PC-3 and DU 145 cells using Electrical Impedance Spectroscopy.
- Utilized a four-terminal setup in a specialized chamber to minimize electrode polarization effects at low frequencies.
Main Results:
- The impedance spectra of PC-3 and DU 145 cells were found to be distinct.
- EIS successfully differentiated between the two prostate cancer cell lines based on their electrical properties.
Conclusions:
- Electrical Impedance Spectroscopy can effectively distinguish between metastatic (PC-3) and non-metastatic (DU 145) prostate cancer cells.
- EIS holds promise as a potential diagnostic tool for identifying cancer cell metastatic potential.
More Related Videos
12:30Electric Cell-substrate Impedance Sensing for the Quantification of Endothelial Proliferation, Barrier Function, and Motility
Published on: March 28, 2014
11:56In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
Published on: May 15, 2014